Kairos Pharma, Ltd.
$1.65
+1.41 (+587.50%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -24.0%
- 3 Months
- -49.6%
- YTD
- -66.8%
- 1 Year
- -82.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 85.6%
- Largest decline max drawdown, since Aug 2025
- -88.2%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.60
Own KAPA?
See how KAPA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.